Goodyer C G, De Stéphano L, Lai W H, Guyda H J, Posner B I
Endocrinology. 1984 Apr;114(4):1187-95. doi: 10.1210/endo-114-4-1187.
Studies were undertaken to determine whether the insulin-like growth factors (IGF-I and -II), bind to specific membrane receptors in the pituitary and brain. Anterior pituitary glands, hypothalami, and brains (minus hypothalami) were obtained from adult male Sprague-Dawley rats (225-300 g) and 15,000 X g membranes prepared by differential centrifugation. Binding of 125I-IGF-I and 125I-IGF-II to all three membrane preparations was specific, time and temperature dependent, reversible, and increased in proportion to increasing concentrations of membrane protein or labeled ligand. Neither the pH of the assay buffer (6.5-8.5) nor the presence or absence of 1 mg/ml bacitracin had any significant effect on the levels of specific binding. In all three membrane preparations IGF-II specific binding was 3-5 times higher than that observed for IGF-I, and unlabeled IGF-II displaced either 125I-IGF-I or 125I-IGF-II better than comparable concentrations of IGF-I. All three membrane preparations showed similar low specific binding of 125I-insulin (1.3-2.2%) and negligible specific binding of 125I-rat GH (less than 0.5%). The presence of specific IGF and insulin receptors in rat anterior pituitary, hypothalamic, and brain tissue is additional evidence that IGFs and insulin are involved in modulating brain and pituitary function.
开展了多项研究以确定胰岛素样生长因子(IGF-I和IGF-II)是否与垂体和大脑中的特定膜受体结合。从成年雄性Sprague-Dawley大鼠(225 - 300克)获取垂体前叶、下丘脑和大脑(不含下丘脑),并通过差速离心制备15,000×g的膜。125I-IGF-I和125I-IGF-II与所有三种膜制剂的结合具有特异性、时间和温度依赖性、可逆性,并且与膜蛋白或标记配体浓度的增加成比例增加。测定缓冲液的pH值(6.5 - 8.5)以及是否存在1 mg/ml杆菌肽对特异性结合水平均无显著影响。在所有三种膜制剂中,IGF-II的特异性结合比IGF-I高3 - 5倍,并且未标记的IGF-II比同等浓度的IGF-I能更好地置换125I-IGF-I或125I-IGF-II。所有三种膜制剂对125I-胰岛素的特异性结合均较低(1.3 - 2.2%),对125I-大鼠生长激素的特异性结合可忽略不计(小于0.5%)。大鼠垂体前叶、下丘脑和脑组织中存在特异性IGF和胰岛素受体,这进一步证明IGF和胰岛素参与调节大脑和垂体功能。